Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Epigenetic signature of MAOA and MAOB genes in mental disorders.

Ziegler C, Domschke K.

J Neural Transm (Vienna). 2018 Sep 21. doi: 10.1007/s00702-018-1929-6. [Epub ahead of print] Review.

PMID:
30242487
2.

Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients.

Pompili M, Gentile G, Scassellati C, Bonvicini C, Innamorati M, Erbuto D, Montebovi F, Ducci G, Forte A, De Pisa E, Ferracuti S, Serafini G, De Luca V, Amore M, Simmaco M, Girardi P.

Neurosci Lett. 2017 Aug 24;656:94-102. doi: 10.1016/j.neulet.2017.07.020. Epub 2017 Jul 14.

PMID:
28716530
3.

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.

Purves-Tyson TD, Owens SJ, Rothmond DA, Halliday GM, Double KL, Stevens J, McCrossin T, Shannon Weickert C.

Transl Psychiatry. 2017 Jan 17;7(1):e1003. doi: 10.1038/tp.2016.257.

4.

Monoamine oxidase and agitation in psychiatric patients.

Nikolac Perkovic M, Svob Strac D, Nedic Erjavec G, Uzun S, Podobnik J, Kozumplik O, Vlatkovic S, Pivac N.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:131-46. doi: 10.1016/j.pnpbp.2016.02.002. Epub 2016 Feb 4.

PMID:
26851573
5.

MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.

Liu Z, Huang L, Luo XJ, Wu L, Li M.

Mol Neurobiol. 2016 Sep;53(7):4319-27. doi: 10.1007/s12035-015-9374-0. Epub 2015 Jul 31.

PMID:
26227907
6.

Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.

Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.

Behav Brain Funct. 2014 Jul 29;10:26. doi: 10.1186/1744-9081-10-26.

7.

Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.

Tybura P, Trześniowska-Drukała B, Bienkowski P, Beszlej A, Frydecka D, Mierzejewski P, Samochowiec A, Grzywacz A, Samochowiec J.

Psychiatry Res. 2014 Oct 30;219(2):261-7. doi: 10.1016/j.psychres.2014.05.039. Epub 2014 Jun 2.

PMID:
24930580
8.

Association study between monoamine oxidase A (MAOA) gene polymorphisms and schizophrenia: lack of association with schizophrenia and possible association with affective disturbances of schizophrenia.

Kim SK, Park HJ, Seok H, Jeon HS, Chung JH, Kang WS, Kim JW, Yu GI, Shin DH.

Mol Biol Rep. 2014 May;41(5):3457-64. doi: 10.1007/s11033-014-3207-5. Epub 2014 Feb 9.

PMID:
24510409
9.

Interaction between MAOA and FOXP2 in association with autism and verbal communication in a Korean population.

Park Y, Won S, Nam M, Chung JH, Kwack K.

J Child Neurol. 2014 Dec;29(12):NP207-11. doi: 10.1177/0883073813511301. Epub 2013 Dec 18.

PMID:
24356376
10.

Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)-a suitable endophenotype of schizophrenia.

Grant P, Kuepper Y, Mueller EA, Wielpuetz C, Mason O, Hennig J.

Front Hum Neurosci. 2013 Jan 24;7:1. doi: 10.3389/fnhum.2013.00001. eCollection 2013.

11.

Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra.

Purves-Tyson TD, Handelsman DJ, Double KL, Owens SJ, Bustamante S, Weickert CS.

BMC Neurosci. 2012 Aug 6;13:95. doi: 10.1186/1471-2202-13-95.

12.

Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.

Tybura P, Samochowiec A, Beszlej A, Grzywacz A, Mak M, Frydecka D, Bieńkowski P, Mierzejewski P, Potemkowski A, Samochowiec J.

Pharmacol Rep. 2012;64(3):528-35.

13.

Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia.

Chung TS, Lung FW.

J Clin Psychopharmacol. 2012 Jun;32(3):394-7. doi: 10.1097/JCP.0b013e31825370f4.

PMID:
22544010
14.

Connectomic intermediate phenotypes for psychiatric disorders.

Fornito A, Bullmore ET.

Front Psychiatry. 2012 Apr 19;3:32. doi: 10.3389/fpsyt.2012.00032. eCollection 2012.

15.

Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia.

Camarena B, Fresán A, Aguilar A, Escamilla R, Saracco R, Palacios J, Tovilla A, Nicolini H.

ISRN Psychiatry. 2012 Apr 19;2012:852949. doi: 10.5402/2012/852949. Print 2012.

16.

Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia.

Chen Y, Zhang J, Zhang L, Shen Y, Xu Q.

Hum Genet. 2012 Jul;131(7):1081-7. doi: 10.1007/s00439-011-1131-5. Epub 2011 Dec 24.

PMID:
22198720
17.

Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population.

Sun Y, Zhang J, Yuan Y, Yu X, Shen Y, Xu Q.

Am J Med Genet B Neuropsychiatr Genet. 2012 Jan;159B(1):104-11. doi: 10.1002/ajmg.b.32009. Epub 2011 Dec 7.

PMID:
22162429
18.

Monoamine oxidase A gene polymorphism and suicide: an association study and meta-analysis.

Hung CF, Lung FW, Hung TH, Chong MY, Wu CK, Wen JK, Lin PY.

J Affect Disord. 2012 Feb;136(3):643-9. doi: 10.1016/j.jad.2011.10.013. Epub 2011 Oct 30.

PMID:
22041522
19.

Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese.

Wei YL, Li CX, Li SB, Liu Y, Hu L.

Behav Brain Funct. 2011 Oct 6;7:42. doi: 10.1186/1744-9081-7-42.

20.

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain.

De Luca V, Souza RP, Viggiano E, Sickert L, Teo C, Zai C, Tiwari AK, Müller DJ, Lieberman JA, Volavka J, Meltzer HY, Kennedy JL.

Hum Psychopharmacol. 2011 Aug;26(6):386-91. doi: 10.1002/hup.1219. Epub 2011 Aug 8.

PMID:
21823169

Supplemental Content

Loading ...
Support Center